Table 1 Demographic data of statin users (n = 272) and non-statin users (n = 272) patients with gallstones
From: Effect of statin use on outcome of symptomatic cholelithiasis: a case-control study
Statin users (n = 272) | No statin (n = 272) | P-value | |
|---|---|---|---|
Females/males | 132/140 (48%/52%) | 132/140 (48%/52%) | 1.000 |
Age (years) | 69 ± 11 (36-93) | 69 ± 11 (36-93) | 0.786 |
Body mass index (Kg/m2) | 29 ± 4.2 | 28 ± 4.9 | 0.499 |
Use of statins | |||
Simvastatin | 73% | 199 | |
Atorvastatiini | 13% | 36 | |
Rosuvastatin | 6% | 15 | |
Fluvastatin | 4% | 11 | |
Pravastatin | 2% | 5 | |
Lovastatin | 1% | 3 | |
Other1 | 1% | 3 | |
Comorbid condition | |||
Hypertension | 161 (59%) | 115 (42%) | < 0.001 |
Diabetes | 48(18%) | 38 (14%) | 0.290 |
Coronary artery disease/ | |||
Coronary heart failure/ | |||
Valvular | 151 (56%) | 71 (26%) | < 0.001 |
Neurological | 50 (18%) | 48 (18%) | 0.456 |
Psychiatric | 16 (6%) | 22 (8%) | 0.401 |
Pulmonary | 32 (12%) | 37 (14%) | 0.303 |
Rheumatoid | 12 (4%) | 12 (4%) | 1.000 |
Malignancy | 26 (10%) | 33 (12%) | 0.408 |
Number of medication | |||
No | 0 | 75 (28%) | |
1-3 drug | 44 (16%) | 88 (32%) | |
> 4 drugs | 228 (84%) | 109 (40%) |